Jacobs Levy Equity Management, Inc Ikena Oncology, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $21.8 Billion
- Q1 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 513,440 shares of IKNA stock, worth $847,176. This represents 0.0% of its overall portfolio holdings.
Number of Shares
513,440
Previous 56,195
813.68%
Holding current value
$847,176
Previous $110,000
562.73%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IKNA
# of Institutions
60Shares Held
32MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$8.28 Million0.89% of portfolio
-
Bvf Inc San Francisco, CA4.77MShares$7.87 Million0.2% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.89MShares$6.42 Million1.46% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$5.84 Million0.11% of portfolio
-
Omega Fund Management, LLC Boston, MA2.25MShares$3.71 Million3.31% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $59.8M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...